Xeloda
CapecitabineSystematic (IUPAC) namepentylaminomethanoateIdentifiersCAS number154361-50-9ATC codeL01BC06PubChem60953DrugBankAPRD00203Chemical dataFormulaC15H22FN3O6 Mol. mass359.35 g/molPharmacokinetic dataBioavailabilityExtensiveProtein binding< 60%MetabolismHepatic, to 5'-DFCR, 5'-DFUR (inactive); neoplastic tissue, 5'-DFUR to active fluorouracilHalf life38–45 minutesExcretionRenal 95.5%, faecal 2.6%Therapeutic considerationsPregnancy cat.D(AU) D(US)Legal statusPrescription Only (S4)(AU) POM(UK) ℞-only(US)RoutesOralCapecitabine (INN) (pronounced /keɪpˈsaɪtəbiːn/) is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. The activation of capecitabine follows a pathway with three enzymatic steps and two intermediary metabolites, 5'-deoxy-5-fluorocytidine (5'-DFCR) and 5'-deoxy-5-fluorouridine (5'-DFUR), to form 5-fluorouracil. Capecitabine is marketed under the trade name Xeloda (Roche).// IndicationsCapecitabine is FDA-approved for:Adjuvant in colorectal cancer Stage III Dukes' C - used as first-line monotherapy.Metastatic colorectal cancer - used as first-line monotherapy, if appropriate.Metastatic breast cancer - used in combination with docetaxel, after failure of anthracycline-based treatment. Also as monotherapy, if the patient has failed paclitaxel-based treatment, and if anthracycline-based treatment has either failed or cannot be continued for other reasons (i.e., the patient has already received the maximum lifetime dose of an anthracycline).In the UK, capecitabine is approved by the National Institute for Health and Clinical Excellence (NICE) for colon and colorectal cancer, and locally advanced or metastatic breast cancer. DoseThe usual starting dose is 2,500 mg/m2/day in two divided doses, 12 hours apart. One cycle includes two weeks of treatment followed by one week without treatment. Cycles can be repeated every three weeks. Dose adjustmentsFor mild renal dysfunction (creatinine clearance 30-50 mL/min), it is recommended to reduce dose by 25%.For severe renal dysfunction (creatinine clearance <30 mL/min), treatment is not recommended.There is no recommendation for hepatic dysfunction.For elderly patients, lower doses may be required due to higher incidences of serious adverse reactions. Side effectsPotential major adverse reactions include:Cardiovascular: EKG changes, myocardial infarction, angina (these may be more common in patients with pre-existing coronary artery disease)Dermatological: Hand-foot syndrome (numbness, tingling, pain, redness, or blistering of the palms of the hands and soles of the feet)Gastrointestinal: Diarrhea (sometimes severe), nausea, stomatitisHematological: Neutropenia, anemia, thrombocytopeniaHepatic: Hyperbilirubinemia Drug interactionsMay interact with warfarin and increase bleeding risk.May inhibit cytochrome CYP2C9 enzyme, and therefore increase levels of substrates such as phenytoin and other substrates of CYP2C9.Much as fluorouracil, the concomitant use of leucovorin may increase both the efficacy and the toxicity of capecitabine. FormulationCapecitabine (as brand-name Xeloda) is available in light peach 150 mg tablets and peach 500 mg tablets.
Xeloda is used for treating women with breast cancer that is resistant to other more commonly-used drugs.. A reader wants to know if Xeloda can also cause strokes.GlaxoSmithKline is seeking FDA approval to market Tykerb in combination with Xeloda for the treatment of advanced breast cancer in women who have received prior therapy, including Herceptin. It also is used following surgery for colorectal cancer if the cancer has spread to lymph nodes (Dukes' C stage). It also is used following surgery for colorectal cancer if the cancer has spread to lymph nodes (Dukes' C stage). It also is used following surgery for colorectal cancer if the cancer has spread to lymph nodes (Dukes' C stage).NCCN adding Xeloda to treat advanced Esophogeal and Gstric Cancer.Buy cheap Xeloda online without prescription from best online pharmacy - huge discount + 12 free pills!!! Xeloda is used for treating women with breast cancer that is resistant to other more commonly-used drugs.. A reader wants to know if Xeloda can also cause strokes.GlaxoSmithKline is seeking FDA approval to market Tykerb in combination with Xeloda for the treatment of advanced breast cancer in women who have received prior therapy, including Herceptin. It
Even more about Xeloda
Xeloda
Features product details for US consumers and healthcare professionals as well as information about breast and colorectal cancer. [Requires Flash]
Read more...
XELODA® (capecitabine)—The First FDA-Approved Oral Chemotherapy
Get information on the benefits of oral chemotherapy and learn more about XELODA.
Read more...
Considering XELODA® (capecitabine) Oral Chemotherapy
... Cancer Drug Breast Cancer Store Cure For Breast Cancer Breast Cancer Chemotherapy Drugs Xeloda ... Привет, Алексей! Неужели в России еще есть места ...
Read more...
injun #576871 — блог о флэш, adobe air, flex и coldfusion ...
Click here to go to www.xeloda.roche.com Information for oncologists and healthcare professionals. Subscribe to the Xeloda online update for the latest searchable data including ...
Read more...
Xeloda : Roche
Полное описание препарата Кселода. Показания, противопоказания, побочные эффекты. Также на сайте ...
Read more...
